Dr. Pradeep Mathur, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 955 Windham Ct, Suite 2, Boardman, OH 44512 Phone: 330-726-9570 Fax: 330-726-9031 |
Dr. Elizabeth Myer, D.O. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 8401 Market St, Boardman, OH 44512 Phone: 330-480-3285 Fax: 330-480-2946 |
Vincent Paolone, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 8166 Market St, Unit B, Boardman, OH 44512 Phone: 330-758-8528 Fax: 330-758-8529 |
Steven M Kalavsky, M.D. Psychiatry & Neurology - Neurology with Special Qualifications in Child Neurology Medicare: Medicare Enrolled Practice Location: 8423 Market St Ste 300, Boardman Medical Pavilion, Boardman, OH 44512 Phone: 330-729-1145 Fax: 330-729-1144 |
Elizabeth Adele Finley-belgrad, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 146 Forest Hill Rd, Boardman, OH 44512 Phone: 330-782-2438 Fax: 330-782-2591 |
Carmen Z Harlan, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 6614 Southern Blvd, Boardman, OH 44512 Phone: 330-746-8056 Fax: 330-746-9152 |
Dr. Nicholas A Atanasoff, D.O. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 819 Mckay Ct Ste 102, Boardman, OH 44512 Phone: 330-259-4849 Fax: 330-629-2847 |
News Archive
Walking is one of the most important motor skills for animals and humans. And for almost all people, being able to walk is deeply essential. In spite of this, researchers are still working to map out which signals and electrical impulses from the brain control our walking.
Cystic fibrosis is a lethal genetic disorder that in France affects one child per 4,500 births. An international team led by scientists at the Institut Fédératif de Recherche Necker-Enfants Malades (CNRS/Inserm/Université Paris Descartes), led by Aleksander Edelman, has recently discovered two new compounds that could be used to treat patients carrying the most common mutation.
Les Laboratoires Servier, France (Servier) and Prognomix Inc., Canada (Prognomix) announced today that they have entered into a research and development agreement aimed at identifying novel targets as part of programs meant to develop innovative type 2 diabetes and metabolic disease treatment.
People who have Alzheimer's disease may be less likely to develop cancer, and people who have cancer may be less likely to develop Alzheimer's disease, according to a new study published in the December 23, 2009, online issue of Neurology®, the medical journal of the American Academy of Neurology.
› Verified 7 days ago